Shanghai Huihe Healthcare Technology Co., Ltd. (referred to as "HuiHe Healthcare") is a high-tech enterprise focused on the research, development, production, and commercialization of cardiovascular interventional medical devices, with its headquarters located in Songjiang District, Shanghai. Driven by the principles of "combining medical expertise with engineering" and "original innovation," HuiHe Healthcare is committed to promoting China-produced high-end medical devices globally.

Taiping Healthcare Fund was established in 2021, with a registered fund size of 10 billion yuan, and is managed by Taiping Innovation Investment Management Co., Ltd. The fund focuses on the fields of biopharmaceuticals, medical devices and diagnostics, medical services, biotechnology, and healthcare informatization, extending to related areas such as health technology and health consumption. It is committed to building a "Insurance + Medical Care and Elderly Care" ecosystem with Taiping characteristics.

Sherpa Investment is a fund management company focused on early-stage and growth-stage healthcare investments. Adhering to the philosophy of "investing early, investing in innovation, and investing accurately," it leverages long-term accumulated industry insights and advantageous resources to address unmet critical clinical needs in major disease areas. The firm builds its investment portfolio around sectors such as gene technology and its applications, biopharmaceuticals, medical devices and diagnostics, and digital healthcare. It expands along the depth of the industry and its upstream and downstream segments, forming enterprise synergies, with investment presence in both China and the United States.